[1]
Triggle, D.J.; Mitchell, J.M.; Filler, R. The pharmacology of physostigmine. CNS Drug Rev., 1998, 4(2), 87-136.
[2]
Brufani, M.; Castellano, C.; Marta, M.; Murroni, F.; Oliverio, A.; Pagella, P.G.; Pavone, F.; Pomponi, M.; Rugarli, P.L. From Physostigmine to Physostigmine Derivatives as New Inhibitors of Cholinesterase. In: Current Research in Alzheimer Therapy: Cholinesterase Inhibitors; Giacobini, E.; Becker, R., Eds.; Tylor & Francis: New York, 1988; pp. 343-355.
[3]
Kulkarni, M.G.; Dhondge, A.P.; Borhade, A.S.; Gaikwad, D.D.; Chavhan, S.W.; Shaikh, Y.B.; Nigdale, V.B.; Desai, M.P.; Birhade, D.R.; Shinde, M.P. Total synthesis of (±)‐physovenine. Eur. J. Org. Chem., 2009, 23, 3875-3877.
[4]
Sneader, W. From ordeal poison to Alzheimer’s therapy. Drug News Perspect., 1999, 12(7), 433-437.
[5]
Kawagishi, H.; Hota, K.; Masuda, K.; Yamaguchi, K.; Yazawa, K.; Shibata, K.; Uzuka, N.; Matahira, Y. Osteoclast-forming suppressive compounds from makomotake, Zizania latifolia Infected with Ustilago esculenta. Biosci. Biotechnol. Biochem., 2006, 70(11), 2800-2802.
[6]
Hayashi, M.; Kim, Y.P.; Takamatsu, S.; Enomoto, A.; Shinose, M.; Takahashi, Y.; Tanaka, H.; Komiyama, K.; Omura, S. Madindoline, a novel inhibitor of IL-6 activity from Streptomyces sp. K93-0711. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot., 1996, 49(11), 1091-1095.
[7]
Kishimoto, T.; Akira, S.; Taga, T. Interleukin-6 and its receptor: a paradigm for cytokines. Science, 1992, 258(5082), 593-597.
[8]
Hirano, T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol., 1998, 16(3-4), 249-284.
[9]
Strassmann, G.; Masui, Y.; Chizzonite, R.; Fong, M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J. Immunol., 1993, 150(6), 2341-2345.
[10]
Yoshizaki, K.; Matsuda, T.; Nishimoto, N.; Kuritani, T.; Taeho, L.; Aozasa, K.; Nakahata, T.; Kawai, H.; Tagoh, H.; Komori, T. Kishimoto, S.; Hirano, T.; Kishimoto, T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood, 1989, 74(4), 1360-1367.
[11]
Takagi, N.; Mihara, M.; Moriya, Y.; Nishimoto, N.; Yoshizaki, K.; Kishimoto, T.; Takeda, Y.; Ohsugi, Y. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum., 1998, 41(12), 2117-2121.
[12]
De La Mata, J.; Uy, H.L.; Guise, T.A.; Story, B.; Boyce, B.F.; Mundy, G.R.; Roodman, G.D. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest., 1995, 95(6), 2846-2852.
[13]
Zhang, X.G.; Bataille, R.; Jourdan, M.; Saeland, S.; Banchereau, J.; Mannoni, P.; Klein, B. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 1990, 76(12), 2599-2605.
[14]
Kulkarni, M.G.; Chavhan, S.W.; Desai, M.P.; Shaikh, Y.B.; Gaikwad, D.D.; Dhondge, A.P.; Borhade, A.S.; Ningdale, V.B.; Birhade, D.R.; Dhatrak, N.R. A short and efficient synthesis of furo[2,3-b]indoles. Tetrahedron Lett., 2010, 51(34), 4494-4496.
[15]
Onaka, T. One-step construction of 2,3,3a,8a-tetrahydrofuro[2,3-b]indole system: An application to physovenine synthesis. Tetrahedron Lett., 1971, 12(46), 4391-4392.
[16]
Hoshino, T.; Kobayashi, T. Synthesis of the d, l-ether. Synthetic experiments on Eserin. IV. Syntheses in the indole group. XIII. Liebigs Ann., 1935, 520(1), 11-19.
[17]
Calvert, M.B.; Sperry, J. A furoindoline synthesis by remote radical functionalization. Tetrahedron Lett., 2012, 53(40), 5426-5429.
[18]
Koag, M.; Lee, S. Discovery of hypoiodite-mediated aminyl radical cyclization lacking a nitrogen radical-stabilizing group: Application to synthesis of an oxazaspiroketal-containing cephalostatin analog. Org. Lett., 2011, 13(18), 4766-4769.
[19]
Suzuki, T.; Choi, J.H.; Kawaguchi, T.; Yamashita, K.; Morita, A.; Hirai, H.; Nagai, K.; Hirsoe, T.; Omura, S.; Sunazuka, T. Makomotindoline from Makomotake, Zizania latifolia infected with Ustilago esculenta. Bioorg. Med. Chem. Lett., 2012, 22(13), 4246-4248.
[20]
Butera, J.A.; Antane, S.A.; Hirth, B.; Lennox, J.R.; Sheldon, J.H.; Norton, N.W.; Warga, D.; Argentieri, T.M. Synthesis and potassium channel opening activity of substituted 10H-benzo[4,5]furo[3,2-b]indole-and 5,10-dihydro-indeno[1,2-b]indole-1-carboxylic acids. Bioorg. Med. Chem. Lett., 2001, 11(16), 2093-2097.
[21]
Clark, A.J.; Jones, K. Cobalt-mediated aryl radical cyclization: A formal synthesis of physovenine. Tetrahedron, 1992, 48(33), 6875-6882.
[22]
Morales-Ríos, M.S.; Santos-Sánchez, N.F.; Fragoso-Vázquez, M.J.; Alagille, D.; Villagómez-Ibarra, J.R.; Joseph-Nathan, P. A convenient preparation of furo[2,3-b]indoles by conjugated addition of organomagnesium reagents to 2-hydroxyindolylidenemalonates. Tetrahedron, 2003, 59(16), 2843-2853.
[23]
Shishido, K.; Azuma, T.; Shibuya, M. Novel and facile route to (+)-physovenine via intramolecular [2+2] cycloaddition reaction. Tetrahedron Lett., 1990, 31(2), 219-220.
[24]
Yamamoto, D.; Sunazuka, T.; Hirose, T.; Kojima, N.; Kaji, E.; Omura, S. Design, synthesis, and biological activities of madindoline analogues. Bioorg. Med. Chem. Lett., 2006, 16(10), 2807-2811.
[25]
Sunazuka, T.; Yoshida, K.; Kojima, N.; Shirahata, T.; Hirsoe, T.; Handa, M.; Yamamoto, D.; Harigaya, Y.; Kuwajima, I.; Omura, S. Total synthesis of (−)-physovenine from (−)-3a-hydroxyfuroindoline. Tetrahedron Lett., 2005, 46(9), 1459-1461.
[26]
Ishibashi, H.; Kobayashi, T.; Machida, N.; Tamura, O. A new efficient route to (±)-physostigmine and (±)-physovenine by means of 5-exo selective aryl radical cyclization of o-bromo-N-acryloylanilides. Tetrahedron, 2000, 56(11), 1469-1473.
[27]
Luo, Y.L.; Yu, Q.S.; Chrisey, L.; Brossi, A. Synthesis of (±)-physovenine and (±)-7-bromophysovenine from intermediates of the synthesis of physostigmines. Heterocycles, 1990, 31(2), 283-287.
[28]
Zhang, T.Y.; Zhang, H. Palladium-catalyzed intramolecular arylation of an anilide enolate, application to an efficient formal total synthesis of physovenine. Tetrahedron Lett., 2002, 43(8), 1363-1365.
[29]
Clark, A.J.; Jones, K. Cobalt-mediated aryl radical cyclisations: A formal synthesis of physovenine. Tetrahedron, 1992, 48(33), 6875-6882.
[30]
Tanaka, K.; Taniguchi, T.; Ogasawara, K. 7,7-Dimethyl-6,8-dioxabicyclo[3.3.0]oct-3-en-2-one as a synthetic equivalent of ketodicyclopentadiene: a new route to (−)-physostigmine, (−)-physovenine, and (−)-aphanorphine. Tetrahedron Lett., 2001, 42(6), 1049-1052.
[31]
Kulkarni, M.G.; Desai, M.P.; Birhade, D.R.; Shaikh, Y.B.; Dhatrak, A.N.; Gannimani, R. A Wittig-olefination-Claisen-rearrangement approach to the 3-methylquinoline-4-carbaldehyde synthesis. J. Org. Chem., 2012, 8, 1725-1729.
[32]
Liu, C.; Yin, Q.; Dai, L.X.; You, S.L. Synthesis of pyrroloindolines and furoindolines via cascade dearomatization of indole derivatives with carbenium ion. Chem. Commun., 2015, 51(27), 5971-5974.
[33]
Zhu, X.; Xu, X.P.; Sun, C.; Chen, T.; Shen, Z.L.; Ji, S.J. I-MCR-Ullmann cascade toward furo[2,3-b]indole scaffold. Tetrahedron, 2011, 67(34), 6375-6381.
[34]
Matsuura, T.; Overman, L.E.; Poon, D.J. Catalytic asymmetric synthesis of either enantiomer of the calabar alkaloids physostigmine and physovenine. J. Am. Chem. Soc., 1998, 120(26), 6500-6503.
[35]
Morales-Ríos, M.; Joseph-Nathan, P. NMR studies of indoles and their N‐carboalkoxy derivatives. Magn. Reson. Chem., 1987, 25(10), 911-918.
[36]
Takano, S.; Goto, E.; Hirama, E.; Ogasawara, K. Enantioselective Synthesis of (-)-Physostigmine. Chem. Pharm. Bull., 1982, 30(7), 2641-2643.
[37]
Sunazuka, T.; Hirose, T.; Shirahata, T.; Harigaya, Y.; Hayashi, M.; Komiyana, K.; Omura, S.; Smith, A.B. Total synthesis of (+)-madindoline a and (−)-madindoline b, potent, selective inhibitors of interleukin 6. Determination of the relative and absolute configurations. J. Am. Chem. Soc., 2000, 122(9), 2122-2123.
[38]
Hirsoe, T.; Sunazuka, T.; Shirahata, T.; Yamamoto, D.; Harigaya, Y.; Kuwajima, I.; Omura, S. Short total synthesis of (+)-madindolines A and B. Org. Lett., 2002, 4(4), 501-503.
[39]
Shishido, K.; Shitara, E.; Komatsu, H.; Hiroya, K.; Fukumoto, K.; Kametani, T. Total syntheses of (.+-.)-physovenine and (.+-.)-physostigmine. An application of tandem electrocyclic-[3,3]sigmatropic reaction of benzocyclobutenes. J. Org. Chem., 1986, 51(15), 3007-3011.
[40]
Takano, S.; Moriya, M.; Ogasawara, K. Enantiocontrolled total syntheses of (-)-physovenine and (-)-physostigmine. J. Org. Chem., 1991, 56(21), 5982-5984.
[41]
ElAzab, A.S.; Taniguchi, T.; Ogasawara, K. An expedient route to the calabar bean alkaloids (−)-physovenine and (−)-physostigmine. Org. Lett., 2000, 2(18), 2757-2759.
[42]
Dhiman, S.; Mathew, J.; Ramasastry, S.S.V. One-pot relay catalysis: divergent synthesis of furo[3,4-b]indoles and cyclopenta[b]indoles from 3-(2-aminophenyl)-1,4-enynols. Org. Biomol. Chem., 2016, 14(24), 5563-5568.
[43]
Ikeda, M.; Ohno, K.; Katsura, M.; Chun, M.W.; Tamura, Y. Reactions of tryptophols and Ná-acetyltryptamines with iodine azide. Formation of 3a-azido-3,3a,8,8a-tetrahydro-2H-furo- and 3a-azido-1,2,3,3a,8,8a-hexahydro-pyrrolo-[2,3-b]indoles. J. Chem. Soc., 1979, 1, 3061-3063.
[44]
Yu, Q.S.; Lu, B.Y.; Pei, X.F. Total synthesis of racemic physostigmine, physovenine and its sulfur analogue by the oxindole-5-o-tetrahydropyranyl ether route. Heterocycles, 1994, 39(2), 519-525.
[45]
Chouhan, M.; Kumar, K.; Sharma, R.; Grover, V.; Nair, V.A. NiCl2.6H2O/NaBH4 in methanol: a mild and efficient strategy for chemoselective deallylation/debenzylation of aryl ethers. Tetrahedron Lett., 2013, 54(34), 4540-4543.
[46]
Goyal, S.; Patel, J.K.; Gangar, M.; Kumar, K.; Nair, V.A. Zirconocene dichloride catalysed one-pot synthesis of pyrroles through nitroalkeneenamine assembly. RSC Adv., 2015, (5), 3187-3195.
[47]
Chouhan, M.; Senwar, K.R.; Sharma, R.; Grover, V.; Nair, V.A. Regiospecific epoxide opening: A facile approach for the synthesis of 3-hydroxy-3-aminomethylindolin-2-one derivatives. Green Chem., 2011, 13(9), 2553-2560.
[48]
Kumar, V.; Kumar, K.; Pal, A.; Khatik, G.L.; Nair, V.A. Aldol reactions of 2-thioxotetrahydropyrimidin-4(1H)-ones: stereoregulations from endo- and exocyclic chiral centres. Tetrahedron, 2013, 69(6), 1747-1754.
[49]
Kumar, K.; Mudshinge, S.R.; Goyal, S.; Gangar, M.; Nair, V.A. A catalyst free, one pot approach for the synthesis of quinoxaline derivatives via oxidative cyclisations of 1,2-diamines and phenacyl bromides. Tetrahedron Lett., 2015, 56(10), 1266-1271.
[50]
Chouhan, M.; Senwar, K.R.; Kumar, K.; Sharma, R.; Nair, V.A. Catalytic C–H activation of aryl acetylenes: A fast assembly of 3-(arylethynyl)-3-hydroxyindolin-2-ones Using CuI/DBU. Synthesis, 2014, 46(2), 195-202.
[51]
Sharma, R.; Kumar, K.; Chouhan, M.; Grover, V.; Nair, V.A. Lithium hydroxide mediated synthesis of 3, 4-disubstituted pyrroles. RSC Adv, 2013, 3(34), 14521-14527.
[52]
Goyal, S.; Patel, B.K.; Sharma, R.; Chouhan, M.; Kumar, K.; Gangar, M.; Nair, V.A. An efficient strategy for the synthesis of syn 1,3-diols via iterative acetate aldol reactions and synthesis of atorvastatin lactone. Tetrahedron Lett., 2015, 56(40), 5409-5412.
[53]
Kumar, K.; More, S.S.; Goyal, S.; Gangar, M.; Khatik, G.L.; Rawal, R.K.; Nair, V.A. A convenient synthesis of 4-alkyl-3-benzoylpyrroles from α, β-unsaturated ketones and tosylmethyl isocyanide. Tetrahedron Lett., 2016, 57(21), 2315-2319.
[54]
Kumar, K.; Siddique, J.; Gangar, M.; Goyal, S.; Rawal, R.K.; Nair, V.A. ZrCl4 catalysed diastereoselective synthesis of spirocarbocyclic oxindoles via [4+2] cycloaddition. Chem. Select., 2016, 1(10), 2409-2412.
[55]
Kumar, K.; Konar, D.; Goyal, S.; Gangar, M.; Chouhan, M.; Rawal, R.K.; Nair, V.A. AlCl3/cyclohexane mediated electrophilic activation of isothiocyanates: an efficient synthesis of thioamides. Chem. Select., 2016, 1(12), 3228.
[56]
Kumar, K.; Konar, D.; Goyal, S.; Gangar, M.; Chouhan, M.; Rawal, R.K.; Nair, V.A. Water-promoted regiospecific azidolysis and copper-catalyzed azide-alkyne cycloaddition: One-pot synthesis of 3-hydroxy-1-alkyl-3-[(4-aryl/alkyl-1H-1,2,3-triazol-1-yl)methyl]indolin-2-ones. J. Org. Chem., 2016, 81(20), 9757-9764.
[57]
Kaur, R.; Manjal, S.K.; Rawal, R.K.; Kumar, K. Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg. Med. Chem., 2017, 25(17), 4533-4552.
[58]
Manjal, S.K.; Kaur, R.; Bhatia, R.; Kumar, K.; Singh, V.; Shankar, R.; Kaur, R.; Rawal, R.K. Synthetic and medicinal perspective of thiazolidinones: A review. Bioorg. Chem., 2017, 75, 406-423.
[59]
Mittal, M.; Kumar, K.; Anghore, D.; Rawal, R.K. ICP-MS: Analytical method for identification and detection of elemental impurities. Curr. Drug Discover. Tech., 2017, 14(2), 106-120.
[60]
Kaur, R.; Choudhry, S.; Kumar, K.; Gupta, M.K.; Rawal, R.K. Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review. Eur. J. Med. Chem., 2017, 132, 108-134.
[61]
Kumar, B.; Singh, V.; Shankar, R.; Kumar, K.; Rawal, R.K. Synthetic and medicinal prospective of structurally modified curcumins. Curr. Topics. Med. Chem., 2017, 17(2), 148-161.
[62]
Talwan, P.; Choudhary, S.; Kumar, K.; Rawal, R.K. Chemical and medicinal versatility of substituted 1, 4-dihydropyridines. Curr. Bioact. Compd., 2017, 13(2), 109-120.
[63]
Kumar, K.; More, S.S.; Khatik, G.L.; Rawal, R.K.; Nair, V.A. A highly stereoselective chiral auxiliary‐assisted reductive cyclization to furoindoline. J. Heterocycl. Chem., 2017, 54(5), 2696-2702.